Abstract:Arsenic is a carcinogenic metalloid toxicant widely found in the natural environment. Acute or prolonged exposure to arsenic causes a series of damages to the organs, mainly the liver, such as hepatomegaly, liver fibrosis, cirrhosis, and even hepatocellular carcinoma. Therefore, it is imperative to seek drugs to prevent arsenic-induced liver injury. Quinazolines are a class of nitrogen heterocyclic compounds with biological and pharmacological effects in vivo and in vitro. This study was designed to investigate the ameliorating effects of quinazoline derivatives on arsenic-induced liver injury and its molecular mechanism. We investigated the mechanism of the quinazoline derivative KZL-047 in preventing and ameliorating arsenic-induced liver injury in vitro by cell cycle and apoptosis. We performed real-time fluorescence quantitative polymerase chain reaction (qPCR) and Western blotting combined with molecular docking. In vivo, the experiments were performed to investigate the mechanism of KZL-047 in preventing and ameliorating arsenic-induced liver injury using arsenic-infected mice. Physiological and biochemical indices of liver function in mouse serum were measured, histopathological changes in liver tissue were observed, and immunohistochemical staining was used to detect changes in the expression of RecQ-family helicases in mouse liver tissue. The results of in vitro experiments showed that sodium arsenite (SA) inhibited the proliferation of L-02 cells, induced apoptosis, blocked the cell cycle at the G1 phase, and decreased the expression of RecQ family helicase; after KZL-047 treatment in arsenic-induced L-02 cells, the expression of RecQ family helicase was upregulated, and the apoptosis rate was slowed, leading to the restoration of the cell viability level. KZL-047 inhibited arsenic-induced oxidative stress, alleviated oxidative damage and lipid peroxidation in vivo, and ameliorated arsenic toxicity-induced liver injury. KZL-047 restored the expression of RecQ family helicase proteins, which is consistent with the results of in vitro studies. In summary, KZL-047 can be considered a potential candidate for the treatment of arsenic-induced liver injury.

Resveratrol, a Natural Antioxidant, Has a Protective Effect on Liver Injury Induced by Inorganic Arsenic Exposure

Resveratrol Protects Against Arsenic Trioxide-Induced Nephrotoxicity by Facilitating Arsenic Metabolism and Decreasing Oxidative Stress

Resveratrol attenuates hepatotoxicity of rats exposed to arsenic trioxide

Attenuation of Arsenic Retention by Resveratrol in Lung of Arsenic Trioxide-Exposed Rats

Resveratrol Ameliorates the Oxidative Damage Induced by Arsenic Trioxide in the Feline Lung.

The Protective Role of Resveratrol in the Sodium Arsenite-Induced Oxidative Damage via Modulation of Intracellular GSH Homeostasis

Resveratrol Alleviates Arsenic Exposure-Induced Liver Fibrosis in Rats by Inhibiting Hepatocyte Senescence

Biochemical Investigation of Therapeutic Potential of Resveratrol Against Arsenic Intoxication

Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway

Hepatoprotective effects of resveratrol on α-amanitin-induced liver toxicity in rats

Effect of Acetyl-l-Carnitine on Antioxidant Status, Lipid Peroxidation, and Oxidative Damage of Arsenic in Rat

Assessing the mechanisms and adjunctive therapy for arsenic-induced liver injury in rats

Protective Effects of Selenium on Oxidative Damage and Oxidative Stress Related Gene Expression in Rat Liver under Chronic Poisoning of Arsenic.

Glutathione Might Attenuate Arsenic-Induced Liver Injury by Modulating the Foxa2-XIAP Axis to Reduce Oxidative Stress and Mitochondrial Apoptosis

Resveratrol Alleviates Inorganic Arsenic-Induced Ferroptosis in Chicken Brain Via Activation of the Nrf2 Signaling Pathway

Nephroprotective Effect of Astaxanthin Against Trivalent Inorganic Arsenic-Induced Renal Injury in Wistar Rats

Hepato-Protective Effect of Resveratrol Against Acetaminophen-Induced Liver Injury is Associated with Inhibition of Cyp-Mediated Bioactivation and Regulation of Sirt1-P53 Signaling Pathways

Inflammation Response after the Cessation of Chronic Arsenic Exposure and Post-Treatment of Natural Astaxanthin in Liver: Potential Role of Cytokine-Mediated Cell-Cell Interactions.

Resveratrol Alleviated T-2 Toxin-Induced Liver Injury via Preservation of Nrf2 Pathway and GSH Synthesis

Inhibition of Histone H3K18 Acetylation-Dependent Antioxidant Pathways Involved in Arsenic-Induced Liver Injury in Rats and the Protective Effect of Rosa roxburghii Tratt Juice

A Novel Quinazoline Derivative Prevents and Treats Arsenic-Induced Liver Injury by Regulating the Expression of RecQ Family Helicase